LIAROZOLE
UNII K0Q29TGV9Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Liarozole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K0Q29TGV9Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 115575-11-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

K0Q29TGV9Y

CAS Registry Number

115575-11-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LIAROZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C17H13ClN4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UGFHIPBXIWJXNA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1433

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

60652

Unique identification number in the NCBI database of chemical substances.

INN ID

6478

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(C(c2cc3[nH]cnc3cc2)c4cc(Cl)ccc4)cncc1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Liarozole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.